InSilc | InSilc: In-silico trials for drug-eluting BVS design, development and evaluation 01-11-2017 - 30-04-2021 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.5. Methods and data H2020-EU.3.1.5.0. Cross-cutting call topics H2020-SC1-2017-CNECT-2 SC1-PM-16-2017 In-silico trials for developing and assessing biomedical products
SILICOFCM | In Silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy 01-06-2018 - 28-02-2022 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.5. Methods and data H2020-EU.3.1.5.0. Cross-cutting call topics H2020-SC1-2017-CNECT-2 SC1-PM-16-2017 In-silico trials for developing and assessing biomedical products
INSIST | IN-Silico trials for treatment of acute Ischemic STroke 01-11-2017 - 30-04-2022 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.5. Methods and data H2020-EU.3.1.5.0. Cross-cutting call topics H2020-SC1-2017-CNECT-2 SC1-PM-16-2017 In-silico trials for developing and assessing biomedical products
STriTuVaD | In Silico Trial for Tuberculosis Vaccine Development 01-02-2018 - 31-01-2023 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.5. Methods and data H2020-EU.3.1.5.0. Cross-cutting call topics H2020-SC1-2017-CNECT-2 SC1-PM-16-2017 In-silico trials for developing and assessing biomedical products
REPO-TRIAL | An in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes 01-02-2018 - 31-01-2024 Show more information EU-Programme-Call Horizon 2020 H2020-EU.3. SOCIETAL CHALLENGES H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being H2020-EU.3.1.5. Methods and data H2020-EU.3.1.5.0. Cross-cutting call topics H2020-SC1-2017-CNECT-2 SC1-PM-16-2017 In-silico trials for developing and assessing biomedical products